DOWNLOAD DATASHEET
InVivoMAb Anti-Human CNR1/CB1 Nanobody (6B7)
Overview
Catalog No. HB822030
Host species Alpaca
Tested applications WB
Species reactivity Human
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Purity >95% as determined by SDS-PAGE.
Clonality Monoclonal
Isotype VHH-8His-Cys-tag
Applications ELISA, Neutralization, WB
Target CNR1, CB1, CANN6, CB-R, CNR, Cannabinoid receptor 1
Purification Purified by Nickel column.
Endotoxin level <0.01 EU/ug
Accession P21554
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID 6B7
Product Usage Information
Application Dilution
WB 1:500-1:2000
Note For research use only. Not suitable for clinical or therapeutic use.
RRID InVivoMAb Anti-Human CNR1/CB1 Nanobody (6B7) (abinScience Cat# HB822030, RRID:AB_3727802)
Description

InVivoMAb Anti-Human CNR1/CB1 Nanobody (6B7) [6B7] (HB822030) is a alpaca monoclonal antibody detecting CNR1 in ELISA, Neutralization. Suitable for Human.

Images


SDS-PAGE
SDS-PAGE for InVivoMAb Anti-Human CNR1/CB1 Nanobody (6B7)

Bioactivity
Detects recombinant CNR1 (Catalog No: HB822012) in indirect ELISA.

Western blot
Western blot analysis was performed using anti-CNR1 monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human CNR1 (Catalog No: HB822012)